Related Experiment Video
Updated: Aug 23, 2025
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.3K
Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation
Francesca DE Felice1, Luca Mazzoni2, Daniela Musio3
1Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy; francesca.defelice@uniroma1.it.
In Vivo (Athens, Greece)
|October 29, 2022
Summary
The Covid-death mean-imputation (CoDMI) algorithm provides unbiased survival estimates for locally advanced rectal cancer patients with Covid-19. This method corrects for Covid-19 deaths, ensuring accurate survival analysis in the pandemic era.
Area of Science:
- Oncology
- Biostatistics
- Epidemiology
Background:
- Locally advanced rectal cancer (LARC) treatment outcomes are crucial.
- The Covid-19 pandemic introduced challenges in survival analysis due to excess mortality.
- Accurate survival estimation is vital for LARC patient management.
Purpose of the Study:
- To report long-term survival results for LARC patients treated with a trimodal approach during the Covid-19 pandemic.
- To demonstrate the clinical application of the Covid-death mean-imputation (CoDMI) algorithm for LARC patients with Covid-19 infection.
- To assess the impact of Covid-19 on survival data and propose a method for unbiased analysis.
Main Methods:
- Analysis of 94 patients treated for primary LARC.
- Calculation of overall survival from diagnosis to the first event (death or last follow-up).
- Application of the CoDMI algorithm to impute expected lifetime for patients who died of Covid-19, using Kaplan-Meier estimates to correct for biased survival data.
Main Results:
- One patient died of Covid-19 (DoC) 52 months post-diagnosis; 16 died of disease (DoD); 77 were censored.
- The CoDMI algorithm estimated the DoC patient's survival to be 79.5 months, extending the observed 52 months.
- This imputation method corrects for the potential bias introduced by Covid-19 related deaths in survival estimations.
Conclusions:
- The CoDMI algorithm yields unbiased overall survival probability in LARC patients with Covid-19 infection.
- This approach enables proper interpretation and utilization of Covid-19 events in survival analyses.
- A user-friendly version of the CoDMI algorithm is publicly available for use in similar research.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
346
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
Related Concept Videos
01:21Cancer Survival Analysis
421
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
421
01:20Comparing the Survival Analysis of Two or More Groups
250
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
250
01:15Assumptions of Survival Analysis
174
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
174
01:18Introduction To Survival Analysis
343
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
343
01:24Kaplan-Meier Approach
229
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
229
01:20Actuarial Approach
113
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
113